Nyfosa AB (publ)

SSE:NYF.ST

88.9 (SEK) • At close February 20, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) SEK.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q3
Revenue 92691990892288088589189584679979171467263458357156055449343038333133332397261240247247234
Cost of Revenue 271242273344249235285339273255267263226182188211177144151147127107109123168271947761
Gross Profit 65567763557863165060655657354452445144645239536038341034228325622422420081179169153170173
Gross Profit Ratio 0.7070.7370.6990.6270.7170.7340.680.6210.6770.6810.6620.6320.6640.7130.6780.630.6840.740.6940.6580.6680.6770.6730.6190.8350.6860.7040.6190.6880.739
Reseach & Development Expenses 000000000000000000000000000000
General & Administrative Expenses 434745505043464747354336342731353628383032142122-142015240
Selling & Marketing Expenses 000000000000000000000000000000
SG&A 434745505043464747354336342731353628383032142122-142015240
Other Expenses -100-623-50-50-43-46-47-47-35-43000-31-35000000000003400
Operating Expenses 3367839495041454239334134332730326626372933142324153215363-1
Operating Income 6226305905295816725145435755444163072,8934503653261,7774103422551,1562102031881,264148154189923173
Operating Income Ratio 0.6720.6860.650.5740.660.7590.5770.6070.680.6810.5260.434.3050.710.6260.5713.1730.740.6940.5933.0180.6340.610.58213.0310.5670.6420.7653.7370.739
Total Other Income Expenses Net -291-748-606-472-1,331-426-304-863-1,683-170274858-1,609390128230139245-49346-53151-32-61193804911-67386
Income Before Tax 331-118-4257-629182257-350-1,1103741,0551,5401,284840776744456826293824592477325182185697441317365345
Income Before Tax Ratio 0.357-0.128-0.0460.062-0.7150.2060.288-0.391-1.3120.4681.3342.1571.9111.3251.3311.3030.8141.4910.5941.9161.5461.4410.9760.5631.9072.671.8381.2831.4781.474
Income Tax Expense 6551854-624115-16-2271037321722313964106-42745164481091621-644545588853
Net Income 266-122-484-687149233-333-8812689811,3221,061701711638497819249659544369309160249652396259278292
Net Income Ratio 0.287-0.133-0.0530.004-0.7810.1680.262-0.372-1.0410.3351.241.8521.5791.1061.221.1170.8881.4780.5051.5331.421.1150.9280.4952.5672.4981.651.0491.1261.248
EPS 1.28-0.59-0.240.07-3.60.781.22-1.74-4.611.45.096.875.553.673.823.462.734.441.353.83.252.21.840.961.843.892.361.551.661.74
EPS Diluted 1.28-0.59-0.240.07-3.60.781.22-1.74-4.611.345.076.855.553.663.823.462.734.441.353.83.252.21.840.961.843.892.361.531.661.74
EBITDA 622630590529-8680561514536349002,9104253653261,7773843050223211202177183147154153133173
EBITDA Ratio 0.6720.6860.650.574-0.98600.630.5740.6340.437004.330.670.6260.5713.1730.6930.61900.5820.6370.6070.5481.8870.5630.6420.6190.5380.739